168 related articles for article (PubMed ID: 11932322)
1. Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification.
Khoo ML; Ezzat S; Freeman JL; Asa SL
J Clin Endocrinol Metab; 2002 Apr; 87(4):1810-3. PubMed ID: 11932322
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.
Khoo ML; Beasley NJ; Ezzat S; Freeman JL; Asa SL
J Clin Endocrinol Metab; 2002 Apr; 87(4):1814-8. PubMed ID: 11932323
[TBL] [Abstract][Full Text] [Related]
3. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
[TBL] [Abstract][Full Text] [Related]
4. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid.
Min HS; Choe G; Kim SW; Park YJ; Park DJ; Youn YK; Park SH; Cho BY; Park SY
Mod Pathol; 2008 Jun; 21(6):748-55. PubMed ID: 18360353
[TBL] [Abstract][Full Text] [Related]
5. Low level of cyclin D1 protein expression in thyroid microcarcinomas from an autopsy series.
Kovacs GL; Stelkovics E; Krenacs L; Gonda G; Goth M; Kovacs L; Gorombey Z; Hubina E; Szabolcs I
Endocrine; 2005 Feb; 26(1):41-4. PubMed ID: 15805584
[TBL] [Abstract][Full Text] [Related]
6. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?
Londero SC; Godballe C; Krogdahl A; Bastholt L; Specht L; Sørensen CH; Pedersen HB; Pedersen U; Christiansen P
Acta Oncol; 2008; 47(3):451-7. PubMed ID: 17906980
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1, Ret and P27 Expression in Papillary Thyroid Microcarcinoma.
Barić A; Marković V; Eterović D; Bedeković V; Kontić M; Juretić Kuščić L; Pešutić Pisac V; Punda A
Acta Clin Croat; 2017 Mar; 56(1):15-20. PubMed ID: 29120119
[TBL] [Abstract][Full Text] [Related]
8. Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease.
Khoo ML; Freeman JL; Witterick IJ; Irish JC; Rotstein LE; Gullane PJ; Asa SL
Arch Otolaryngol Head Neck Surg; 2002 Mar; 128(3):253-7. PubMed ID: 11886339
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 protein expression in human thyroid gland and thyroid cancer.
Temmim L; Ebraheem AK; Baker H; Sinowatz F
Anat Histol Embryol; 2006 Apr; 35(2):125-9. PubMed ID: 16542178
[TBL] [Abstract][Full Text] [Related]
10. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
[TBL] [Abstract][Full Text] [Related]
11. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
Wang S; Lloyd RV; Hutzler MJ; Safran MS; Patwardhan NA; Khan A
Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index.
Basolo F; Caligo MA; Pinchera A; Fedeli F; Baldanzi A; Miccoli P; Iacconi P; Fontanini G; Pacini F
Thyroid; 2000 Sep; 10(9):741-6. PubMed ID: 11041450
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 expression in primary thyroid carcinomas.
Sporny S; Slowinska-Klencka D; Ratynska M
Neuro Endocrinol Lett; 2005 Dec; 26(6):815-8. PubMed ID: 16380680
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
16. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
Cheema Y; Olson S; Elson D; Chen H
J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma.
Kim JY; Cho H; Rhee BD; Kim HY
Acta Cytol; 2002; 46(4):679-83. PubMed ID: 12146030
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 expression as a prognostic parameter in papillary carcinoma of the thyroid.
Muro-Cacho CA; Holt T; Klotch D; Mora L; Livingston S; Futran N
Otolaryngol Head Neck Surg; 1999 Feb; 120(2):200-7. PubMed ID: 9949353
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland.
Mitselou A; Peschos D; Dallas P; Charalabopoulos K; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2004 Dec; 26(4):282-6. PubMed ID: 15627060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]